Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Treatment of Severe Eczema Rash Under the Breast

Initial Management

  • The American College of Dermatology recommends initiating treatment with a very high potency topical corticosteroid such as clobetasol propionate 0.05% applied twice daily for up to 2 weeks, combined with liberal emollient use and avoidance of irritants 1
  • Apply emollients liberally and frequently throughout the day, especially after bathing, to help manage eczema symptoms 1
  • Use oil-in-water creams or ointments rather than alcohol-containing lotions, which can be irritating in this intertriginous area 2, 1
  • Avoid hot showers and excessive soap use to prevent further irritation 3

Reassessment and Adjustment

  • If significant improvement is achieved after 2 weeks, step down to a medium potency topical corticosteroid and continue liberal emollient use 1
  • If minimal or no improvement is observed, consider secondary bacterial infection, particularly with Staphylococcus aureus, and add flucloxacillin (or erythromycin if penicillin-allergic) 2, 3, 4

Maintenance Therapy

  • Transition to medium potency topical corticosteroid applied twice weekly to previously affected areas to reduce relapse risk 1
  • Maintain daily emollient use indefinitely to help control eczema symptoms 1
  • For long-term management in sensitive areas, consider tacrolimus 0.1% ointment once daily as a steroid-sparing agent 4, 1

Management of Complications

  • Flucloxacillin is the antibiotic of choice for Staphylococcus aureus infection, with erythromycin as an alternative for penicillin allergy or flucloxacillin resistance 3, 4
  • Sedating antihistamines may provide short-term relief during severe flares, primarily through sedative effects 2, 4

Important Precautions

  • Prolonged use of high potency steroids can lead to hypothalamic-pituitary-adrenal axis suppression and skin atrophy, particularly in the inframammary fold 1
  • Limit very high potency formulations to short courses (2-4 weeks maximum) to minimize risks 1

REFERENCES

1

Severe Eczema Flare Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Nummular Eczema [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Treatment of Dyshidrotic Eczema [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025